Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Gene Therapy00:59

Gene Therapy

27.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.9K
Bacterial Transformation01:33

Bacterial Transformation

14.0K
14.0K
Bacterial Transformation01:33

Bacterial Transformation

62.1K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
62.1K
Transduction01:16

Transduction

2.3K
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
2.3K
Recombinant DNA01:09

Recombinant DNA

104.5K
Overview
104.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Formyl peptide receptor 1 agonism selectively suppresses mitochondria-driven neutrophil extracellular trap formation while preserving antibacterial immunity.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Neutrophil extracellular traps in the animal model of adenine-induced chronic kidney disease.

PloS one·2026
Same author

Selective mitochondrial dysfunction and redox collapse induced by an indole chalcone in breast cancer cells.

Chemico-biological interactions·2026
Same author

Cisplatin - induced peripheral neuropathy and biomarkers of gut microbial translocation in testicular germ cell tumor survivors.

Frontiers in immunology·2026
Same author

Neonatal testosterone exposure modulates exploration and object avoidance without exacerbating autism-like behavior in Shank3b-deficient mice.

Hormones and behavior·2026
Same author

Extracellular heme:DNA complexes promote oxidative stress and inflammation during lupus-associated hemolysis.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

AKT-mTOR/P53 PathwayDriven RapamycinAlpelisib Efficacy in Animal Models of TIE2Mutant Venous Malformations.

Frontiers in bioscience (Landmark edition)·2026
Same journal

Dual Role of Nitric Oxide in Tumor Immunity and Its Therapeutic Application.

Frontiers in bioscience (Landmark edition)·2026
Same journal

The Metabolic States of Cancer-Associated Fibroblasts: Targeting Stromal Reprogramming to Impede Tumor Progression and Immune Evasion.

Frontiers in bioscience (Landmark edition)·2026
Same journal

Functional Changes in Mitochondrial Subpopulations of Left Ventricular Cardiomyocytes in Post-Infarction Rats During the Subacute Stage of Remodeling.

Frontiers in bioscience (Landmark edition)·2026
Same journal

TRPM7 Channel-Mediated Mitochondrial Oxidative Stress Induces Dysfunction of Müller Cells Under High Glucose and Low Mg<sup>2+</sup> Stress.

Frontiers in bioscience (Landmark edition)·2026
Same journal

Navigating the Redox Precipice: Metabolic Gatekeeping as a Therapeutic Window in Pancreatic Precancer.

Frontiers in bioscience (Landmark edition)·2026
See all related articles

Related Experiment Video

Updated: Mar 12, 2026

Bioluminescent Bacterial Imaging In Vivo
05:06

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

16.1K

Gene therapy using bacterial vectors.

Peter Celec1, Roman Gardlik2

  • 1Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Sasinkova 4, 811 08 Bratislava, Slovakia, petercelec@gmail.com.

Frontiers in Bioscience (Landmark Edition)
|November 5, 2016
PubMed
Summary
This summary is machine-generated.

Bacteria offer two gene therapy strategies: bactofection for gene transfer and alternative methods for controlled protein delivery. Both show promise but require improved safety and efficiency for clinical use.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

1.0K

Related Experiment Videos

Last Updated: Mar 12, 2026

Bioluminescent Bacterial Imaging In Vivo
05:06

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

16.1K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

1.0K

Area of Science:

  • Biotechnology
  • Microbiology
  • Gene Therapy

Background:

  • Bacteria present novel strategies for gene therapy, including bactofection and alternative prokaryotic expression systems.
  • These methods offer unique advantages for applications like gene substitution, DNA vaccination, and targeted protein delivery.

Purpose of the Study:

  • To review the advantages and challenges of using bacterial vectors in gene therapy.
  • To summarize current applications of bacteria-mediated gene therapy in biomedical research.

Main Methods:

  • Review of existing literature on bacterial gene therapy strategies.
  • Analysis of bactofection and alternative gene therapy approaches.
  • Examination of transkingdom RNA interference as a specific application.

Main Results:

  • Bactofection is suitable for gene substitution and DNA vaccination.
  • Alternative gene therapy excels at in situ protein delivery and intracellular treatments.
  • Bacterial vectors have shown potential in treating solid tumors and gut infections.

Conclusions:

  • Bacterial gene therapy offers diverse applications but faces challenges in clinical translation.
  • Significant improvements in safety and efficiency are necessary for widespread clinical adoption.